Quotient Therapeutics, which will have offices in Mass. and the United Kingdom, wants to develop drugs that target illnesses caused by genetic changes that occur as people age.
/PRNewswire/ Flagship Pioneering, the bioplatform innovation company, today unveiled Quotient Therapeutics, a company pioneering somatic genomics, the study.
Researchers from the Wellcome Sanger Institute compared the genomes of 16 species and found animals with a slower rate of genetic changes have longer lifespans.